Sale!

Carcinoid Tumor Panel Test

Original price was: 2,600 د.إ.Current price is: 2,340 د.إ.

-10%

The Carcinoid Tumor Panel Test is a sophisticated diagnostic tool designed to detect and analyze specific markers associated with carcinoid tumors. Carcinoid tumors are a type of neuroendocrine tumor that usually grow slowly and can occur in various parts of the body, but most commonly in the gastrointestinal tract or the lungs. These tumors can produce and release hormones into the bloodstream, leading to a range of symptoms, including flushing, diarrhea, and wheezing, depending on the location and size of the tumor.

The test aims to provide comprehensive insights into the genetic makeup of the tumor, helping healthcare professionals in making accurate diagnoses, determining the prognosis, and tailoring personalized treatment plans for patients. By evaluating a panel of genes and biomarkers associated with carcinoid tumors, this test can also aid in identifying potential therapeutic targets, thereby optimizing treatment strategies.

Offered by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the Carcinoid Tumor Panel Test is priced at 2340 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by a team of highly skilled professionals, ensuring that patients receive reliable and accurate test results. The cost of the test reflects the intricate technology and expertise required to analyze the genetic and molecular components of carcinoid tumors.

For patients suspected of having a carcinoid tumor or those undergoing treatment, this panel test represents a critical step towards understanding their condition better and managing it effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CARCINOID TUMOR PANEL Test

At DNA Labs UAE, we offer the CARCINOID TUMOR PANEL test, a diagnostic test used to detect and diagnose carcinoid tumors. Carcinoid tumors are a type of neuroendocrine tumor that can develop in various organs, including the lungs, gastrointestinal tract, and pancreas.

Test Components

  • 5-HIAA (5-Hydroxy Indole Acetic Acid), 24 Hour Urine
  • Chromogranin A
  • Serotonin (5-HT), Serum

Test Cost

The cost of the CARCINOID TUMOR PANEL test is 2340.0 AED.

Sample Condition

For this test, we require a sample of 3 mL (2 mL min.) serum from 1 SST and 2 mL (1 mL min.) plasma from 1 Lavender Top (EDTA) tube. Additionally, a 50 mL (10 mL min.) aliquot of 24-hour urine is needed. The urine should be collected with an appropriate volume of 50% HCl to maintain a pH between 1-2. Do not use concentrated HCl. Please record the 24-hour volume on the test request form and urine container. The sample should be shipped frozen without thawing. Proton pump inhibitor medications should be discontinued for at least 2 weeks prior to sample collection. The patient should strictly avoid certain foods (banana, kiwi, walnut, avocado, brinjal, pineapple, plum, tomato) and drugs (Fluorouracil, Melphalan, Paracetamol & Acetaminophen, Heparin, L-dopa, Reserpine, Salicylates, Chlorpromazine, Imipramine, Isoniazid, MAO inhibitors, Phenothiazines, Promethazine), as well as alcoholic beverages, caffeine, tea/coffee, tobacco, and strenuous exercise for at least 72 hours before and during specimen collection.

Report Delivery

The sample should be submitted by Tuesday at 9 am, and the report will be delivered on Friday.

Method

The CARCINOID TUMOR PANEL test is performed using HPLC-EC (High-Performance Liquid Chromatography with Electrochemical Detection) method.

Test Type

The CARCINOID TUMOR PANEL test falls under the category of Disorders of the Endocrine System.

Doctor

This test is typically requested by an Endocrinologist.

Test Department

The CARCINOID TUMOR PANEL test is conducted in the HPLC department.

Pre Test Information

Prior to sample collection, it is important to discontinue the use of proton pump inhibitor medications for at least 2 weeks. The patient should strictly avoid certain foods (banana, kiwi, walnut, avocado, brinjal, pineapple, plum, tomato) and drugs (Fluorouracil, Melphalan, Paracetamol & Acetaminophen, Heparin, L-dopa, Reserpine, Salicylates, Chlorpromazine, Imipramine, Isoniazid, MAO inhibitors, Phenothiazines, Promethazine), as well as alcoholic beverages, caffeine, tea/coffee, tobacco, and strenuous exercise for at least 72 hours before and during specimen collection.

Test Details

The CARCINOID TUMOR PANEL test is a diagnostic test used to detect and diagnose carcinoid tumors. This type of tumor can develop in various organs, including the lungs, gastrointestinal tract, and pancreas. The panel test includes several different laboratory tests that measure specific biomarkers associated with carcinoid tumors, such as serotonin, chromogranin A, neuron-specific enolase (NSE), and 5-hydroxyindoleacetic acid (5-HIAA). Elevated levels of these biomarkers in the blood or urine can indicate the presence of a carcinoid tumor. The test results can help healthcare providers determine the location and extent of the tumor, as well as monitor its progression or response to treatment.

The CARCINOID TUMOR PANEL test is typically ordered if a person presents with symptoms suggestive of a carcinoid tumor, such as flushing, diarrhea, abdominal pain, or bronchial obstruction. It may also be used to monitor individuals who have been previously diagnosed with a carcinoid tumor.

It is important to note that while the CARCINOID TUMOR PANEL test can be helpful in diagnosing carcinoid tumors, it is not definitive. Additional imaging tests, such as CT scans or MRIs, may be necessary to confirm the presence and location of the tumor. A biopsy may also be performed to obtain a tissue sample for further analysis.

Test Name CARCINOID TUMOR PANEL Test
Components *5-HIAA (5-Hydroxy Indole Acetic Acid), 24 Hour Urine *Chromogranin A *Serotonin (5-HT), Serum
Price 2340.0 AED
Sample Condition 3 mL (2 mL min.) serum from 1 SST AND 2 mL (1 mL min.) plasma from 1 Lavender Top (EDTA) tube AND 50 mL (10 mL min.) aliquot of 24-hour urine. Collect urine with appropriate volume of 50% HCl to maintain pH between 1\u0192??2. Do not use concentrated HCl. Record 24 hour volume on test request form and urine container. Ship frozen. DO NOT THAW. Proton pump inhibitor medications should be discontinued for at least 2 weeks prior to sample collection. Patient should strictly avoid banana, kiwi, walnut, avocado, brinjal, pineapple, plum, tomato & drugs like Fluorouracil, Melphalan, Paracetamol & Acetaminophen, Heparin, L-dopa, Reserpine, Salicylates, Chlorpromazine, Imipramine, Isoniazid, MAO inhibitors, Phenothiazines, Promethazine, alcoholic beverages, caffeine, tea\/coffee, tobacco and strenuous exercise at least 72 hrs before and during specimen collection.
Report Delivery Sample Tue by 9 am; Report Fri
Method HPLC-EC, TRACE
Test type Disorders of Endocrine System
Doctor Endocrinologist
Test Department: HPLC
Pre Test Information Proton pump inhibitor medications should be discontinued for at least 2 weeks prior to sample collection. Patient should strictly avoid banana, kiwi, walnut, avocado, brinjal, pineapple, plum, tomato & drugs like Fluorouracil, Melphalan, Paracetamol & Acetaminophen, Heparin, L-dopa, Reserpine, Salicylates, Chlorpromazine, Imipramine, Isoniazid, MAO inhibitors, Phenothiazines, Promethazine, alcoholic beverages, caffeine, tea/coffee, tobacco and strenuous exercise at least 72 hrs before and during specimen collection.
Test Details

The CARCINOID TUMOR PANEL test is a diagnostic test used to detect and diagnose carcinoid tumors. Carcinoid tumors are a type of neuroendocrine tumor that can develop in various organs, such as the lungs, gastrointestinal tract, and pancreas.

The panel test includes several different laboratory tests that measure specific biomarkers associated with carcinoid tumors. These biomarkers may include serotonin, chromogranin A, neuron-specific enolase (NSE), and 5-hydroxyindoleacetic acid (5-HIAA).

Elevated levels of these biomarkers in the blood or urine can indicate the presence of a carcinoid tumor. The test results can help healthcare providers determine the location and extent of the tumor, as well as monitor its progression or response to treatment.

The CARCINOID TUMOR PANEL test is typically ordered if a person presents with symptoms suggestive of a carcinoid tumor, such as flushing, diarrhea, abdominal pain, or bronchial obstruction. It may also be used to monitor individuals who have been previously diagnosed with a carcinoid tumor.

It is important to note that while the CARCINOID TUMOR PANEL test can be helpful in diagnosing carcinoid tumors, it is not definitive. Additional imaging tests, such as CT scans or MRIs, may be necessary to confirm the presence and location of the tumor. A biopsy may also be performed to obtain a tissue sample for further analysis.